Anti-Inflammatory Effect of Fucoidan from Costaria costata Inhibited Lipopolysaccharide-Induced Inflammation in Mice
Marine Drugs · 02.09.2024 · 22 (9) · 401
DOI: 10.3390/md22090401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 02.09.2024. Verfasst von Wei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai 201508, China. Hauptthemen laut MEDLINE: Polysaccharides, Lipopolysaccharides, Anti-Inflammatory Agents, Mice, Inbred C57BL. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Seaweed extracts, especially fucoidan, are well known for their immune-modulating abilities. In this current study, we extracted fucoidan from Costaria costata, a seaweed commonly found in coastal Asia, and examined its anti-inflammatory effect. Fucoidan was extracted from dried C. costata (FCC) using an alcohol extraction method at an extraction rate of 4.5 ± 0.21%. The extracted FCC comprised the highest proportion of carbohydrates, along with sulfate and uronic acid. The immune regulatory effect of FCC was examined using bone marrow-derived dendritic cells (BMDCs). Pretreatment with FCC dose-dependently decreased the lipopolysaccharide (LPS)-induced upregulation of co-stimulatory molecules and major histocompatibility complex. In addition, FCC prevented morphological changes in LPS-induced BMDCs. Moreover, treatment of LPS-induced BMDCs with FCC suppressed the secretion of pro-inflammatory cytokines. In C57BL/6 mice, oral administration of FCC suppressed LPS-induced lung inflammation, reducing the secretion of pro-inflammatory cytokines in the bronchoalveolar lavage fluid. Finally, the administration of FCC suppressed LPS-induced sepsis. Therefore, FCC could be developed as a health supplement based on the observed anti-inflammatory effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai 201508, China.
- Department of Biochemistry and Molecular Biology, Brain Korea 21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
- Department of Microbiology, Brain Korea 21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
ORCID-Profile: Wei Zhang, Peter C W Lee
Förderung
- National Research Foundation of Korea
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Basic Research Program through the National Research Foundation of Korea
Zitieren
APA
Zhang, W., Lee, P. C. W., & Jin, J. O. (2024). Anti-Inflammatory Effect of Fucoidan from Costaria costata Inhibited Lipopolysaccharide-Induced Inflammation in Mice. Marine Drugs, 22(9), 401. https://doi.org/10.3390/md22090401
Vancouver
Zhang W, Lee PCW, Jin JO. Anti-Inflammatory Effect of Fucoidan from Costaria costata Inhibited Lipopolysaccharide-Induced Inflammation in Mice. Marine Drugs. 2024;22(9):401. doi:10.3390/md22090401
BibTeX
@article{Zhang2024,
author = {Zhang, Wei and Lee, Peter C W and Jin, Jun-O},
title = {Anti-Inflammatory Effect of Fucoidan from Costaria costata Inhibited Lipopolysaccharide-Induced Inflammation in Mice},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {9},
pages = {401},
doi = {10.3390/md22090401}
}
EUVIMED